Altimmune, Inc. — Director's Dealing 2012

Jun 26, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PHARMATHENE, INC (PIP)
CIK: 0001326190
Period of Report: 2012-06-22

Reporting Person: McCleary Joel (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-06-22	Stock option (right to buy)	$1.45	A	20000	Acquired	2022-06-22	Common Stock (20000)	Direct

Footnotes

F1: On June 22, 2012, the date the stock option was granted, the closing price of the Issuer's common stock was $1.45 per share.